Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myeloid, Acute 1Infections 1Graft vs Host Disease 1Congenital Abnormalities 1

Interventions

Cyclophosphamide 62Tacrolimus 52Methotrexate 39Mycophenolic Acid 36Busulfan 35fludarabine phosphate 34Cyclosporine 32Antilymphocyte Serum 32fludarabine 28Sirolimus 23Peripheral Blood Stem Cell Transplantation 22Melphalan 22Radiotherapy 21Methylprednisolone 20Whole-Body Irradiation 19Filgrastim 17thymoglobulin 14Thiotepa 10Stem Cell Transplantation 9Granulocyte Colony-Stimulating Factor 9Hematopoietic Stem Cell Transplantation 7Cord Blood Stem Cell Transplantation 7ruxolitinib 6Rituximab 6Etoposide 6Transplantation 5Therapeutics 5Prednisone 5Flow Cytometry 5Cytarabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Bronchoalveolar Lavage × Other hematologic neoplasm × Clear all
NCT00462657 2013-08-26

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

National Cancer Institute (NCI)

Phase NA Unknown
200 enrolled
LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Infections, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡